Seroatlas · Human Serome Atlas

IL9R

Interleukin-9 receptor

Also known as: CD129, IL9R_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q01113
Gene
IL9R
Ensembl
ENSG00000124334
Chromosome
X
Canonical length
521 aa
Protein class
CD markers, Predicted membrane proteins
Secretome location
Intracellular and membrane

OverviewNCBI Gene

The protein encoded by this gene is a cytokine receptor that specifically mediates the biological effects of interleukin 9 (IL9). The functional IL9 receptor complex requires this protein as well as the interleukin 2 receptor, gamma (IL2RG), a common gamma subunit shared by the receptors of many different cytokines. The ligand binding of this receptor leads to the activation of various JAK kinases and STAT proteins, which connect to different biologic responses. This gene is located at the pseudoautosomal regions of X and Y chromosomes. Genetic studies suggested an association of this gene with the development of asthma. Multiple pseudogenes on chromosome 9, 10, 16, and 18 have been described. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

521 residues, UniProt reviewed canonical sequence.

>Q01113|IL9R
     1  MGLGRCIWEG WTLESEALRR DMGTWLLACI CICTCVCLGV SVTGEGQGPR SRTFTCLTNN
    61  ILRIDCHWSA PELGQGSSPW LLFTSNQAPG GTHKCILRGS ECTVVLPPEA VLVPSDNFTI
   121  TFHHCMSGRE QVSLVDPEYL PRRHVKLDPP SDLQSNISSG HCILTWSISP ALEPMTTLLS
   181  YELAFKKQEE AWEQAQHRDH IVGVTWLILE AFELDPGFIH EARLRVQMAT LEDDVVEEER
   241  YTGQWSEWSQ PVCFQAPQRQ GPLIPPWGWP GNTLVAVSIF LLLTGPTYLL FKLSPRVKRI
   301  FYQNVPSPAM FFQPLYSVHN GNFQTWMGAH GAGVLLSQDC AGTPQGALEP CVQEATALLT
   361  CGPARPWKSV ALEEEQEGPG TRLPGNLSSE DVLPAGCTEW RVQTLAYLPQ EDWAPTSLTR
   421  PAPPDSEGSR SSSSSSSSNN NNYCALGCYG GWHLSALPGN TQSSGPIPAL ACGLSCDHQG
   481  LETQQGVAWV LAGHCQRPGL HEDLQGMLLP SVLSKARSWT F

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against IL9R can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
1
Mean surface accessibility (rSASA)
0.51
Highest tissue expression
4 nTPM

Expression across tissuesHPA

Tissue

  • urinary bladder: 4 nTPM
  • thymus: 3.1 nTPM
  • lymph node: 2.3 nTPM
  • tonsil: 2.1 nTPM
  • spleen: 1.7 nTPM
  • small intestine: 1.6 nTPM

Single-cell type

  • mast cells: 15 nCPM
  • t-cells: 6.5 nCPM
  • innate lymphoid cells: 5.8 nCPM
  • nk-cells: 3.9 nCPM
  • thymocytes: 3.4 nCPM
  • hematopoietic stem cells: 1.9 nCPM

Immune cell

  • eosinophil: 3.5 nTPM
  • naive B-cell: 1.9 nTPM
  • T-reg: 1.4 nTPM
  • neutrophil: 1 nTPM
  • memory B-cell: 0.9 nTPM
  • memory CD8 T-cell: 0.6 nTPM

Brain region

  • basal ganglia: 0.8 nTPM
  • amygdala: 0.7 nTPM
  • cerebral cortex: 0.7 nTPM
  • hippocampal formation: 0.7 nTPM
  • spinal cord: 0.6 nTPM
  • thalamus: 0.6 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.87
gnomAD pLI
0
gnomAD missense Z
-2.27
DepMap mean gene effect
-0.14
DepMap dependency class
selective

OntologyGO

Biological processes

Molecular functions

  • interleukin-9 binding
  • interleukin-9 receptor activity

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of IL9R in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads IL9R as an antibody target. Whether an autoantibody or antibody against IL9R could matter depends on whether native IL9R is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

IL9R is annotated at the cell surface, where native IL9R is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label IL9R as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/IL9R. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...